Introduction
Human campylobacteriosis and salmonellosis are the most frequently reported foodborne bacterial infections in Europe. In 2014, notification rates in the European Union (EU) were 71.0 cases per 100 000 population (corresponding to approximately 236 900 cases) for campylobacteriosis and 23.4 cases per 100 000 population (approximately 88 700 cases) for salmonellosis [1] . In the same year, in Switzerland, the notification rate for Campylobacter infections was 92.9 cases per 100 000 population (approximately 7600 cases) and 15.2 cases per 100 000 population (approximately 1200 cases) for Salmonella infections [1] . During the mid-1990s, the annual number of notified human Campylobacter infections surpassed that of Salmonella infections in Switzerland [2] . This was owing to a reduction of human salmonellosis following the introduction of control measures in the egg and poultry industry, such as mandatory screening of layer hens, in the early 1990s [2] . So far, similar control measures for Campylobacter are lacking and campylobacteriosis is currently the most frequently notified foodborne disease in Switzerland [2] . In Switzerland, notifiable diseases are monitored by the Federal Office of Public Health (FOPH) through the National Notification System for Infectious Diseases (NNSID) [3, 4] . Laboratory-based surveillance of Campylobacter and Salmonella infections, as defined by the Epidemics Act of 1970 and its related ordinances, captured only those cases that tested positive [5] [6] [7] . Since the implementation of the new Epidemics Act at the beginning of 2016, the total number of tests conducted for these two pathogens, including the number of positive results, must be reported annually as aggregated numbers, stratified by month and test method [4, 8] . Hence, denominator data to help draw inferences from surveillance data about the epidemiological situation in the community have not been collected so far. The number of stool tests performed depends on the healthcare-seeking behaviour of patients with diarrhoea and the stool sampling rate of treating physicians [9] [10] [11] . As not all individuals affected by acute gastroenteritis seek medical care or have a stool sample examined for enteric pathogens, there are likely to be many undetected (at community level) and unreported (at healthcare level) campylobacteriosis and salmonellosis cases [12, 13] . Hence, changes in notification rates do not necessarily reflect an epidemiological trend, but could be attributable to changes in healthcare-seeking behaviour or stool sampling rates. A more informed interpretation of surveillance data is made possible by calculating positivity rates (proportion of positive tests among all tests performed). Because positivity rate calculations also consider denominator data, they adjust for the number of tests [14, 15] . We analysed laboratory data for stool tests performed for Campylobacter spp. and Salmonella spp. by Swiss diagnostic laboratories over a 10-year period to better interpret the trends of campylobacteriosis and salmonellosis case notifications seen in the NNSID.
Materials and methods

Selection of diagnostic laboratories
The study aimed to include private diagnostic laboratories from all geographical and linguistic regions of Switzerland to reach an optimal representation of the campylobacteriosis cases reported to the NNSID between 2003 and 2012. Eleven private diagnostic laboratories, each reporting more than 1000 campylobacteriosis cases during that decade, were contacted and invited to provide data for the study. The case-based laboratory data requested comprised patients' demographic characteristics (sex, age, canton of residence, personal identification code assigned by laboratory) and test characteristics (pathogen tested, test result, date of test, test method) on all Campylobacter and Salmonella tests performed between 2003 and 2012.
Analysis of positivity rates
Datasets from individual laboratories were transformed uniformly, merged and analysed with STATA™ Version 13.1 (Stata Corporation; College Station, TX, USA). Firstly, double entries, repeated tests and tests for patients without Swiss residency were excluded. The following rulesbased on disease durations and durations of organism excretion [16] -were applied to identify and exclude repeated tests: (i) control or follow-up tests, irrespective of result, following a positive result within 42 days for both, Campylobacter and Salmonella; (ii) negative tests following a negative result within 10 days (Campylobacter) or 21 days (Salmonella); and (iii) negative tests followed by a positive result within 10 days (Campylobacter) or 21 days (Salmonella). The patient population was characterised by sex, age, diagnostic laboratory, test year and residence by greater region (corresponding to the Nomenclature of Units for Territorial Statistics (NUTS) 2 level [17] ). Age groups for statistical analyses were predefined. Residence by greater region was based on the patients' canton of residence (NUTS 3 level). Descriptive analysis of positivity rates -defined as positive tests divided by total tests performed -and exploratory logistic regression analyses of predictors for and seasonality of positive tests were performed. Characteristics of laboratory-confirmed cases of campylobacteriosis and salmonellosis were additionally compared with national surveillance data. Time trends of annual positivity rates were investigated using stratification and direct standardisation for age groups and sex. Thus, the population of individuals tested from 2003 to 2012 was used as the reference population. The seasonality of monthly and weekly positivity rates was assessed by calculating positivity rates from laboratory data from the whole observation period pooled by month or calendar week.
Univariable and multivariable regression models
In a first step, univariable logistic regression analyses were performed to estimate the effect of sex, age group, laboratory, residence by greater region, test week, test month and test year on the test result. Afterwards, a multivariable logistic regression model estimated the unconfounded effects of sex, age groups, laboratories, residence by greater region and test year on the test result. The effect of seasonal within-year variations on test outcome were investigated with a second multivariable logistic regression model including test month and adjustments for sex, age groups, laboratories, residence by greater region and test year. For this model, the test month with a positivity rate closest to the mean positivity rate of all test months was used as a baseline and test year was introduced as a random effect. The significance of variables in the multivariable models was assessed by likelihood ratio tests and the category of each variable with the most observations (except for test month) was used as a baseline to make the model more robust. Patients with missing information on the canton of residence were assigned the greater region of their corresponding laboratory. fig. 1 ). For both diseases, annual test numbers decreased by at least 6% for the age groups <5 years and 5-9 years, and increased by at least 31% in the older age groups. The median age of patients tested for Campylobacter was 42 years (range <1-108 years) and 41 years (range: <1-108 years) for Salmonella. Patients' age differed significantly between laboratories and test years for both pathogens (Kruskal-Wallis test: p <0.01 for all four tests). Slightly more tests were conducted among females than among males for Campylobacter (54.8%) and for Salmonella (54.3%). The sex ratio differed between laboratories and test years for both pathogens (chi-square test: p <0.01 for all four tests). The patients' residence by greater region was associated with the geographical location of the laboratory that performed the test.
Ethics statement
Annual positivity rates overall and by laboratory Annual Campylobacter positivity rates standardised for age and sex increased by 46.1% from 2003 (7.6%) to 2012 (11.1%) ( fig. 2 ). Annual standardised Salmonella positivity rates showed an inverse trend and decreased by 44.4% from 2003 (2.7%) to 2012 (1.5%). Campylobacter positivity rates stratified by laboratory (and standardised for age and sex) showed similar annual trends (supplementary fig. S1 in appendix 1). The annual positivity rates of laboratory C were remarkably lower throughout the investigated period compared with other laboratories. Laborato- Annual positivity rates by sex and age groups The annual Campylobacter positivity rates for males and females increased by 43.6% (from 9.4 to 13.5%) and by 45.2% (from 6.2 to 9.0%), respectively, from 2003 to 2012. In the same decade, annual Campylobacter positivity rates by age group increased for all age groups. The largest increase was observed for the age group ≥85 years (193.7%) followed by the 5-9-year-olds (131.9%). Compared with 2003, annual Campylobacter positivity rates of sex-specific age groups were higher in 2012, except for females in the age group 10-14 years ( fig. 3a ). Annual Campylobacter positivity rates were generally higher for males than for females over the entire observation period. For males and females in the age groups <5 years, 5-9 years and ≥85 years, similar annual Campylobacter positivity rates were observed at the beginning of the decade but rates were later slightly higher for males in the age group ≥85 years and for females in the age groups <5 years and 5-9 years. Annual Salmonella positivity rates decreased from 3.3% to 1.6% (−51.5%) for males and from 2.5% to 1.2% (−52.0%) for females between 2003 and 2012. Annual positivity rates decreased for all age groups between 2003 and 2012 except for the age group 20-24 years, for which the rate remained rather stable. The largest relative decrease of positivity rates was observed for the age groups 10-14 years and ≥85 years, where rates decreased from 10.5 to 3.7% (−64.8%) and from 0.8 to 0.2% (−75.0%), respectively. Sex-specific Salmonella positivity rates were similar or slightly higher for males compared to females in all age groups although for some age groups, positivity rates varied strongly between years ( fig. 3b ).
Seasonal trends in stool sampling and positivity rates
The number of tests performed for Campylobacter and Salmonella started to increase in spring ( fig. 4 panels a and c, fig. 5 panels a and c) . Test numbers peaked in late August (calendar week 34) after a brief and strong temporary decline at the beginning of the month (calendar week 31). Afterwards, the number of tests decreased until the end of the year. Monthly test numbers were lowest in February for Campylobacter and Salmonella, even though calendar week 1 was the week with the fewest tests performed. After a continuous increase during spring, monthly Campylobacter positivity rates peaked during summer months, with the highest monthly rate occurring in July (13.8%) ( fig. 4 panels b and d) . Likewise, monthly Salmonella positivity rates started increasing during the spring. They peaked twice, first in late summer (August) and then in the autumn, with the highest rate occurring in October (3.1%) ( fig. 5 panels b and d) . The highest weekly positivity rate for Campylobacter (17.3%) was in calendar week 1 (January), whereas the peak of weekly Salmonella positivity rates (3.5%) was in calendar week 43 (October). The lowest monthly positivity rates for Campylobacter and Salmonella were in February (5.3%) and March (1.1%), respectively. The seasonal trends of Campylobacter and Salmonella positivity rates were also observable for sex-and age-specific positivity rates although less pronounced in certain groups. 
Regression analyses
Discussion
Annual Campylobacter positivity rates standardised for age and sex increased from 2003 to 2012, whereas standardised Salmonella positivity rates decreased. During the same time period, campylobacteriosis notification rates increased from 72.7 to 105.5 notifications per 100 000 population, whereas salmonellosis notification rates decreased from 29.8 to 15.4 per 100 000 population. Campylobacter positivity rates were generally higher for males than females in all age groups. Monthly and weekly Campylobacter positivity rates showed a distinct seasonality, with a peak during the summer months and again at the beginning of the year, which was independent of sex and age group. Salmonella positivity rates showed a similar seasonality, but peaked in autumn. Annual Salmonella positivity rates were similar or slightly higher for males than for females, with the highest rates observed in the younger age groups, <5, 5-9 and 10-14 years. The observed seasonality and annual trends of positivity rates for both pathogens are congruent with reports from other countries [14, 18] .
Annual positivity rates in relation to NNSID notification rates
Annual positivity rates of Campylobacter and Salmonella standardised for age and sex and annual NNSID notification rates showed similar trends. Multiple testing, data duplication or simultaneous testing of several pathogens could potentially affect both numerator and denominator data in different ways. However, similar trends were observed for the standardised annual positivity rates presented here and for the crude, non-standardised positivity rates calculated from raw data from all eight laboratories included in the study (supplementary fig. S2, appendix 1) . The stool test data analysed for this study originated mainly from culture-based test methods, which used to be the standard diagnostic method for detecting Campylobacter and Salmonella. Campylobacter, Salmonella and Shigella are often tested simultaneously [19] . The observed increase of test numbers in our study was partially due to a single laboratory (laboratory A), where the number of tests increased 3.5 times for Campylobacter and 3.8 times for Salmonella between 2003 and 2012. This laboratory was founded a few years before the study period. For the remaining laboratories (B, C, D, E), a smaller increase of 32.0% for Campylobacter tests and of 29.0% for Salmonella tests was observed. An increase in testing frequency has also been observed in other European countries [14, 20] , except in the Netherlands, where testing frequency remained rather stable [21] . Testing frequencies are largely influenced by physicians' stool sampling behaviour and patients' healthcare-seeking behaviour [14, [22] [23] [24] [25] . It is also possible that laboratories in the study increased their market shares. The increase of Campylobacter notification rates is probably due to a combination of increasing test numbers and an upward epidemiological trend in the population, as suggested by the increase in positivity rates. The decrease of Salmonella notification rates presumably reflects an epidemiological trend in the population, as the notification rate decreased at the same time that testing frequency increased. The increase of campylobacteriosis cases in the population, together with the co-testing of Salmonella and Campylobacter, is probably responsible for the increase of Salmonella test numbers. In summary, notification rates are influenced by both epidemiological trends in the population and test numbers. More infections in the population will lead to higher notification rates and fewer infections will lead to lower noti-fication rates. On the other hand, increasing test numbers can lead to the detection of more cases in the population, i.e., higher notification rates without necessarily reflecting an increase in disease frequency. Consequently, an observed increase in notification rates does not necessarily represent an actual increase of disease frequency in the population. A change in test numbers can be due to a number of factors such as changes in the prevalence of risk factors leading to testing, altered healthcare-seeking behaviour, and changes in physicians' testing practices, human susceptibility, and pathogenicity. Assessing the interplay of notification rates and test numbers by positivity rates provides more insights into the epidemiological situation in the population than one of these measures alone. Nevertheless, understanding underlying reasons for changes in one of these measures requires further investigation.
Positivity rates in relation to age and sex A remarkable increase in Campylobacter positivity rates was observed for the age groups 5-9 years and ≥85 years (+131.9% and +193.7%). Test numbers for the age group 5-9 years decreased during the observation period (−6.1%), and they more than doubled for the age group ≥85 years (+131.5%). During the same time period, notification rates for the ≥85 years age group increased by 94.9% (47.2-92.0 per 100 000 population) and for the 5-9 years age group by 30.7% (55.3-72.3 per 100 000 population) [2] . It was found that adults and the elderly suffered increasingly more frequently from campylobacteriosis; this could be related to the frequent use of proton pump inhibitors and comorbidities in these age groups [2, 26, 27] . Others have also observed increasing test numbers among the elderly and related it to changes (increases) in healthcare-seeking and physicians' testing behaviour [14, 18, 24] . Additionally, the Swiss population aged ≥85 years increased by 29% from 2003 to 2012, which probably also contributed to the observed increase in test numbers [28] . Salmonella notification rates and annual sex-specific positivity rates showed similar decreasing trends. The strongest decreases in age-specific annual Salmonella positivity rates were observed for the age groups 10-14 years and ≥85 years (−64.8% and −75.0%, respectively). At the same time, notification rates dropped by 55.4% (39.2-17.5 per 100 000 population) for the 10-14 year age group and by 55.6% (23.9-10.6 per 100 000 population) for the ≥85 years group. It appears, therefore, that these decreases are true epidemiological trends. Age-specific Salmonella positivity rates tended to be slightly higher for males but did not remarkably differ between sexes. Similar observations have been made for corresponding NNSID data [2] . The increasing trend in Campylobacter positivity rates was similar for males and females. Also, male and female notification rates to the NNSID likewise increased during this time [2] . Both positivity rates and notification rates for Campylobacter were higher among males than among females in nearly all age groups. Higher positivity rates for males have also been observed by others [18] . Higher stool sampling rates have been reported for male patients in Canada [18] and for female patients in Wales [14] . Sexspecific differences in healthcare seeking or in risk exposures could account for this observation.
Seasonality of positivity rates and notification rates
Monthly and weekly Campylobacter and Salmonella positivity rates showed seasonal trends corresponding to the NNSID notification rates, which peaked during the summer months and, for Campylobacter, also at the beginning of the year [2] . Summer peaks of Campylobacter and Salmonella positivity rates have also been described previously [18] . Monthly and weekly test numbers also peak in summer. The seasonal variation of test numbers could indicate seasonality of acute gastroenteritis, a temporal variation in the medical care-seeking behaviour of affected individuals and in the proportion of patients being tested. For instance, returning travellers are more likely to undergo stool diagnostics [24, 25, 29] , leading to increased test numbers during the public school holiday season in the summer. The combination of high test numbers and high positivity rates in summer and autumn generates the observed peak in case numbers in the NNSID [2] . Peaks of Campylobacter and Salmonella notification rates during summer months are observed in most European countries [1, 2, 27, 30, 31] . The prevalence of Campylobacter in broiler flocks and the contamination of chicken meat with Campylobacter at retail are higher during summer months than during the rest of the year [31] [32] [33] [34] . This probably explains the observed seasonality as poultry meat from broilers is the main source of Campylobacter infections in Switzerland [35] [36] [37] . However, it seems that the summer peak is not caused by a single common source of infection and is more likely driven by multiple sources of animal and environmental exposures and climatic conditions [27, 31, 38, 39 ]. An additional reason for the summer peak in Switzerland and parts of the EU could be related to the culture of barbequing during summer, which provides multiple occasions for disease transmission through undercooking of and cross-contamination by poultry and red meat [40] [41] [42] [43] . Travel abroad is a known risk factor for contracting campylobacteriosis [42] [43] [44] [45] -also in Switzerland [46, 47] -and a large proportion of notified Salmonella infections in Switzerland is travel-related [48] . Hence, travelling probably contributes to the observed seasonality of campylobacteriosis and salmonellosis test numbers and case notifications in Switzerland. The highest weekly positivity rate for Campylobacter was found in calendar week 1 when test numbers were lowest. Notification rates of campylobacteriosis in Switzerland show a strong annual increase over Christmas and New Year ("winter peak"). A similar peak in notification data at the beginning of January has also been observed in Germany [30] and in the Campylobacter surveillance data of The European Surveillance System [1] . In Switzerland, the major driver for the winter peak is frequent consumption of meat fondue at festive occasions around this time, especially if it includes chicken meat [47] . The low test numbers over the festive season in December and January are probably related to a different healthcare-seeking behaviour and restricted access to healthcare services during the holiday period. Therefore, the winter peak in Campylobacter notification rates is probably attenuated and does not reveal the full magnitude of the problem.
Strengths and limitations
In Switzerland, private diagnostic laboratories operate on a regional or national level and predominantly serve the practices of general practitioners and medical specialists. The study did not consider hospital-based laboratories as their patient profile generally differs from the patient profile in private practices at the primary care level. Hospitalised patients are likely to be more severely affected by acute gastroenteritis and to undergo more extensive diagnostic testing. Hence, their pre-test probability for a positive Campylobacter or Salmonella test result is different from that of patients consulting at primary care practices [18] . The catchment population of the participating laboratories is not known. Therefore, it was not possible to describe the catchment population, adjust for potential changes therein or to estimate any population-based indicators like stool sampling rates. Similarly, we could not assess how well the data of the five participating laboratories represent the whole tested population in Switzerland, given the latter is not known. We could only assess the representativeness of the patient population by comparing "our" positively tested patients with all notified cases (and hence, supposedly, all positively tested patients in Switzerland;  table 1 and table 2) . From this comparison we conclude that estimated positivity rates are likely to represent accurately the epidemiological trends and situation in Switzerland as median age and the sex-ratio of cases identified in participating laboratories and in cases from the NNSID were comparable.
Conclusions
The study results support the assertion that the increase in notification rates of campylobacteriosis and the decrease in notification rates of salmonellosis are epidemiological trends in the population. These trends cannot be solely explained by changing test numbers. Still, we believe it is important to continuously assess test numbers or positivity rates to note changes in stool testing frequency that could lead to changes in case numbers seen in the notification system. This becomes especially important in the light of the increasing use of multiplex PCR panels where multiple pathogens are tested simultaneously and, hence, test numbers can change substantially [49] . The annual collection of test numbers of selected notifiable diseases as stipulated under the newly enforced Swiss Epidemics Act will allow for continuous assessment of positivity rates in the future. 
